LGT Capital Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.3M Sell
472,976
-131,386
-22% -$11.7M 2.14% 18
2025
Q4
$47.8M Sell
604,362
-161,340
-21% -$12.6M 2.37% 16
2025
Q3
$61.2M Sell
765,702
-38,489
-5% -$3.28M 2.97% 14
2025
Q2
$73.1M Sell
804,191
-192,709
-19% -$17.6M 3.23% 10
2025
Q1
$93.4M Sell
996,900
-255,110
-20% -$22.8M 4.15% 7
2024
Q4
$114M Buy
1,252,010
+260,620
+26% +$24.9M 4.33% 7
2024
Q3
$103M Buy
991,390
+21,770
+2% +$2.22M 3.58% 9
2024
Q2
$94.1M Buy
969,620
+31,030
+3% +$2.86M 3.21% 11
2024
Q1
$84.5M Buy
938,590
+288,830
+44% +$24.5M 2.64% 13
2023
Q4
$51.8M Buy
649,760
+85,450
+15% +$6.42M 1.55% 24
2023
Q3
$40.1M Buy
564,310
+8,900
+2% +$665K 1.44% 25
2023
Q2
$42.8M Sell
555,410
-142,270
-20% -$11M 1.48% 23
2023
Q1
$52.4M Hold
697,680
1.46% 23
2022
Q4
$55M Sell
697,680
-8,730
-1% -$655K 1.61% 22
2022
Q3
$49.6M Buy
706,410
+6,560
+0.9% +$514K 1.52% 23
2022
Q2
$56.1M Sell
699,850
-153,960
-18% -$12M 1.71% 22
2022
Q1
$64.7M Buy
853,810
+218,780
+34% +$17.3M 1.84% 22
2021
Q4
$54.2M Buy
635,030
+552,730
+672% +$43.2M 1.44% 29
2021
Q3
$6.22M Sell
82,300
-98,770
-55% -$7.84M 0.19% 58
2021
Q2
$14.7M Sell
181,070
-289,500
-62% -$23.7M 0.42% 40
2021
Q1
$37.1M Sell
470,570
-11,880
-2% -$931K 1.21% 26
2020
Q4
$41.3M Sell
482,450
-548,830
-53% -$45.4M 1.43% 25
2020
Q3
$79.6M Sell
1,031,280
-249,678
-19% -$19M 3.34% 11
2020
Q2
$93.8M Buy
1,280,958
+165,433
+15% +$11.8M 4.65% 5
2020
Q1
$74M Sell
1,115,525
-128,955
-10% -$9.09M 4.76% 6
2019
Q4
$85.7M Buy
1,244,480
+527,860
+74% +$36M 5.08% 3
2019
Q3
$52.7M Buy
716,620
+51,520
+8% +$3.74M 3.47% 7
2019
Q2
$47.7M Sell
665,100
-38,400
-5% -$2.73M 3.51% 6
2019
Q1
$48.2M Sell
703,500
-273,180
-28% -$17.6M 3.56% 6
2018
Q4
$58.1M Buy
976,680
+3,300
+0.3% +$206K 4.82% 4
2018
Q3
$65.2M Buy
973,380
+106,720
+12% +$7.11M 5.06% 2
2018
Q2
$56.2M Buy
866,660
+234,245
+37% +$15.3M 4.38% 2
2018
Q1
$45.3M Buy
632,415
+139,010
+28% +$10M 3.88% 3
2017
Q4
$37.2M Buy
493,405
+74,280
+18% +$5.42M 3.48% 5
2017
Q3
$30.5M Buy
419,125
+97,505
+30% +$7.03M 3.07% 6
2017
Q2
$23.8M Buy
321,620
+106,580
+50% +$7.91M 2.39% 13
2017
Q1
$15.7M Buy
215,040
+1,360
+0.6% +$95.2K 1.79% 24
2016
Q4
$14M Sell
213,680
-18,410
-8% -$1.26M 1.9% 20
2016
Q3
$17.2M Buy
232,090
+4,000
+2% +$296K 2.41% 13
2016
Q2
$16.7M Sell
228,090
-51,270
-18% -$3.65M 2.9% 8
2016
Q1
$19.7M Buy
279,360
+36,850
+15% +$2.45M 3.56% 3
2015
Q4
$16.2M Sell
242,510
-36,740
-13% -$2.44M 3.64% 3
2015
Q3
$17.7M Buy
279,250
+14,650
+6% +$957K 5.18% 2
2015
Q2
$17.3M Buy
264,600
+77,440
+41% +$5.25M 4.92% 4
2015
Q1
$13M Buy
187,160
+95,900
+105% +$6.63M 3.35% 9
2014
Q4
$6.31M Buy
91,260
+72,160
+378% +$4.87M 1.61% 29
2014
Q3
$1.25M Sell
19,100
-500
-3% -$33K 0.32% 47
2014
Q2
$1.34M Buy
+19,600
New +$1.31M 0.31% 49

Other funds holding CL

LGT Capital Partners's CL Position: Q1 2026 in Review

LGT Capital Partners reduced its Colgate-Palmolive (CL) stake by 22% in Q1 2026, selling an estimated $11.7M and leaving 472,976 shares worth $40.3M. The position accounts for 2.14% of the portfolio, ranked #18.

LGT Capital Partners first reported a position in CL in Q2 2014 and has held it in 48 quarters since. The position peaked at $114M in Q4 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • LGT Capital Partners held 472,976 shares of Colgate-Palmolive worth $40.3M as of Q1 2026.
  • LGT Capital Partners sold 131,386 Colgate-Palmolive shares in Q1 2026, an estimated $11.7M.
  • Colgate-Palmolive made up 2.14% of LGT Capital Partners's portfolio in Q1 2026, its #18 holding.
  • LGT Capital Partners first reported a position in Colgate-Palmolive in Q2 2014 and has held it in 48 quarters since.
  • LGT Capital Partners's Colgate-Palmolive position peaked at $114M in Q4 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on LGT Capital Partners's 13F filing for Q1 2026, filed 11 May 2026.